CureVac N.V.
Status: Publicly traded
Direct answer
CureVac N.V. is publicly traded on NASDAQ under the ticker CVAC.
CureVac N.V. is a biopharmaceutical company currently in the clinical stage, specializing in creating innovative medical treatments leveraging messenger ribonucleic acid (mRNA) technology. Its portfolio encompasses various mRNA-based prophylactic vaccines. Among these is CV2CoV, an mRNA vaccine candidate addressing SARS-CoV-2, presently in Phase 1 clinical investigation. Another key candidate, CV7202, an mRNA...
Can you invest in CureVac N.V.?
Yes. CureVac N.V. is publicly traded on NASDAQ under the ticker CVAC.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for CureVac N.V.
Detailed equity research is provided by MarketSnap.